Cite
MLA Citation
F. Castagnetti et al.. “P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATMENT OF ELDERLY CML PATIENTS: EXTENDED 3-YEAR FOLLOW-UP AND FINAL RESULTS OF THE BEST STUDY.” HemaSphere, vol. 6, n.d., pp. 593–594. http://access.bl.uk/ark:/81055/vdc_100158013638.0x000011